Advaxis to Present at Cantor Fitzgerald’s 2nd Annual Healthcare Conference
PRINCETON, N.J., July 08, 2016 (GLOBE NEWSWIRE) -- Advaxis, Inc. (NASDAQ:ADXS), a clinical stage biotechnology company developing cancer immunotherapies, today announced that Daniel J. O’Connor, President, Chief Executive Officer and Director of Advaxis, …